Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Visweswaran Ravikumar

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Oncoscience|March 21, 2018
High-dimensional regression analysis links magnetic resonance imaging features and protein expression and signaling pathway alterations in breast invasive carcinomaMichael Lehrer, Anindya Bhadra, Sathvik Aithala, et al.
Cell Stem Cell|September 4, 2024
Inflammation-induced epigenetic imprinting regulates intestinal stem cellsDongchang Zhao, Visweswaran Ravikumar, Tyler J Leach, et al.
Science Translational Medicine|March 18, 2021
RNA-seq of human T cells after hematopoietic stem cell transplantation identifies <i>Linc00402</i> as a regulator of T cell alloimmunityDaniel Peltier, Molly Radosevich, Visweswaran Ravikumar, et al.
The Journal of Clinical Investigation|March 24, 2020
Mature myelin maintenance requires Qki to coactivate PPARβ-RXRα-mediated lipid metabolismXin Zhou, Chenxi He, Jiangong Ren, et al.
Neoplasia (New York, N.Y.)|January 9, 2023
Subclonal evolution and expansion of spatially distinct THY1-positive cells is associated with recurrence in glioblastomaWajd N Al-Holou, Hanxiao Wang, Visweswaran Ravikumar, et al.
JCI Insight|July 13, 2023
LSD1 promotes prostate cancer reprogramming by repressing TP53 signaling independently of its demethylase functionAnbarasu Kumaraswamy, Zhi Duan, Diana Flores, et al.
The Journal of Clinical Investigation|September 20, 2022
H3.3-G34 mutations impair DNA repair and promote cGAS/STING-mediated immune responses in pediatric high-grade glioma modelsSantiago Haase, Kaushik Banerjee, Anzar A Mujeeb, et al.
Antioxidants & Redox Signaling|February 28, 2023
Metabolomic Profiles of Human Glioma Inform Patient SurvivalAndrew J Scott, Luis O Correa, Donna M Edwards, et al.
Science Translational Medicine|October 13, 2021
Epigenetically defined therapeutic targeting in H3.3G34R/V high-grade gliomasStefan R Sweha, Chan Chung, Siva Kumar Natarajan, et al.
Cell Systems|October 1, 2018
A Pan-Cancer Analysis Reveals High-Frequency Genetic Alterations in Mediators of Signaling by the TGF-β SuperfamilyAnil Korkut, Sobia Zaidi, Rupa S Kanchi, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Oncoscience|March 21, 2018
High-dimensional regression analysis links magnetic resonance imaging features and protein expression and signaling pathway alterations in breast invasive carcinomaMichael Lehrer, Anindya Bhadra, Sathvik Aithala, et al.
Cell Stem Cell|September 4, 2024
Inflammation-induced epigenetic imprinting regulates intestinal stem cellsDongchang Zhao, Visweswaran Ravikumar, Tyler J Leach, et al.
Science Translational Medicine|March 18, 2021
RNA-seq of human T cells after hematopoietic stem cell transplantation identifies <i>Linc00402</i> as a regulator of T cell alloimmunityDaniel Peltier, Molly Radosevich, Visweswaran Ravikumar, et al.
The Journal of Clinical Investigation|March 24, 2020
Mature myelin maintenance requires Qki to coactivate PPARβ-RXRα-mediated lipid metabolismXin Zhou, Chenxi He, Jiangong Ren, et al.
Neoplasia (New York, N.Y.)|January 9, 2023
Subclonal evolution and expansion of spatially distinct THY1-positive cells is associated with recurrence in glioblastomaWajd N Al-Holou, Hanxiao Wang, Visweswaran Ravikumar, et al.
JCI Insight|July 13, 2023
LSD1 promotes prostate cancer reprogramming by repressing TP53 signaling independently of its demethylase functionAnbarasu Kumaraswamy, Zhi Duan, Diana Flores, et al.
The Journal of Clinical Investigation|September 20, 2022
H3.3-G34 mutations impair DNA repair and promote cGAS/STING-mediated immune responses in pediatric high-grade glioma modelsSantiago Haase, Kaushik Banerjee, Anzar A Mujeeb, et al.
Antioxidants & Redox Signaling|February 28, 2023
Metabolomic Profiles of Human Glioma Inform Patient SurvivalAndrew J Scott, Luis O Correa, Donna M Edwards, et al.
Science Translational Medicine|October 13, 2021
Epigenetically defined therapeutic targeting in H3.3G34R/V high-grade gliomasStefan R Sweha, Chan Chung, Siva Kumar Natarajan, et al.
Cell Systems|October 1, 2018
A Pan-Cancer Analysis Reveals High-Frequency Genetic Alterations in Mediators of Signaling by the TGF-β SuperfamilyAnil Korkut, Sobia Zaidi, Rupa S Kanchi, et al.
Pageof 3